Team CHM will be participating in the 2026 TCS New York City Marathon to raise funds for the Choroideremia Research Foundation (CRF).
Choroideremia (CHM) is a rare, inherited retinal disease that affects approximately 1 in 50,000 individuals and causes progressive vision loss, often leading to complete blindness. Currently, there are no approved treatments or cures for CHM. Funds raised through Team CHM support critical research, education, and resources for individuals and families affected by this condition.
Please note: Registering to become a fundraiser does not provide entry into the 2026 TCS New York City Marathon.
If you have questions, please contact us at info@curechm.org for assistance.
Saving sight is our vision. Building hope is how we’ll get there.